Pacira Pharmaceuticals (PCRX)

Add to Watchlists
Create an Alert
31.25 +0.70  +2.29% NASDAQ Feb 23, 20:00 Delayed 2m USD

Pacira Pharmaceuticals Additional Paid In Capital (Quarterly)

View 4,000+ financial data types
View Full Chart

Pacira Pharmaceuticals Additional Paid In Capital (Quarterly) Chart

Pacira Pharmaceuticals Historical Additional Paid In Capital (Quarterly) Data

View and export this data going back to 2009. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2017 Upgrade
June 30, 2017 Upgrade
March 31, 2017 Upgrade
Dec. 31, 2016 Upgrade
Sept. 30, 2016 Upgrade
June 30, 2016 Upgrade
March 31, 2016 Upgrade
Dec. 31, 2015 Upgrade
Sept. 30, 2015 Upgrade
June 30, 2015 Upgrade
March 31, 2015 Upgrade
Dec. 31, 2014 Upgrade
Sept. 30, 2014 Upgrade
June 30, 2014 Upgrade
March 31, 2014 Upgrade
Dec. 31, 2013 Upgrade
Sept. 30, 2013 Upgrade
June 30, 2013 Upgrade
March 31, 2013 Upgrade
Dec. 31, 2012 Upgrade
Sept. 30, 2012 Upgrade
June 30, 2012 Upgrade
March 31, 2012 Upgrade
Dec. 31, 2011 Upgrade
Sept. 30, 2011 Upgrade
June 30, 2011 Upgrade
March 31, 2011 Upgrade
Dec. 31, 2010 Upgrade
Sept. 30, 2010 Upgrade
June 30, 2010 Upgrade
Dec. 31, 2009 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Additional Paid in Capital

Additional Paid-in Capital is the amount received from equity investors that is greater than the stock's par value. Par value is usually set low so investors will record most of the amounts as additional paid-in-capital. Par value is usually $0.01.

Lets say a company issues 100 shares at $1 each. The par value is $1. If the company does an initial public offering at $5 per share, then the additional paid-in capital would be $400.

Learn More

View Additional Paid In Capital (Quarterly) for PCRX

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

PCRX Additional Paid In Capital (Quarterly) Benchmarks

United Therapeutics Upgrade
Hill-Rom Holdings Upgrade
Madrigal Pharmaceuticals Upgrade

PCRX Additional Paid In Capital (Quarterly) Range, Past 5 Years

Minimum Upgrade Mar 2013
Maximum Upgrade Sep 2017
Average Upgrade

PCRX Additional Paid In Capital (Quarterly) Excel Add-In Codes

  • Metric Code: additional_paid_in_capital
  • Latest data point: =YCP("PCRX", "additional_paid_in_capital")
  • Last 5 data points: =YCS("PCRX", "additional_paid_in_capital", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.